The latest report from Finland: a lesson in expectations
Article Abstract:
Coronary heart disease has many different causes, and its progress varies from person to person. In addition, risk factors such as cigarette smoking, cholesterol levels and diabetes mellitus vary in their effects upon individuals. These and other confounding factors have made the study and prevention of heart disease a very complicated process. Timo E. Strandberg and his colleagues, in an article in the September 4, 1991 issue of the Journal of the American Medical Association, reported the surprising findings of a study of intervention to lower the risk factors for coronary heart disease. The intervention group suffered significantly more deaths from cardiovascular and other causes than the control group, both during the study and during the 11 year follow-up. However, the study was relatively small, and the role of chance cannot be ruled out. The publication of unusual results in this type of study serves a very useful purpose by provoking discussion and pointing out areas of persisting ignorance. This study cannot be dismissed, and must be replicated so that, if there are excess deaths caused by preventive measures, individuals at risk can be identified or treatment methods can be changed. At this time, most of the evidence suggests that decreasing the risk factors for heart disease does in fact decrease the likelihood of death from cardiovascular disease. (Consumer Summary produced by Reliance Medical Information, Inc.)
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1991
User Contributions:
Comment about this article or add new information about this topic:
Triglyceride, high-density lipoprotein, and coronary heart disease
Article Abstract:
There is considerable evidence that high-density lipoprotein cholesterol (HDL-C) and triglycerides (TG) are related to the development of coronary heart disease (CHD). High blood levels of HDL-C appear to protect against CAD and elevated TG levels may increase the risk of CHD. A National Institutes of Health (NIH) panel recommends measuring HDL-C in addition to total cholesterol in all individuals and including a TG measurement in those who have elevated total cholesterol, CHD or risk factors for CHD. Several measurements should be taken several weeks apart to account for the natural variability in levels. Individuals who have elevated TG or low HDL-C should be encouraged to change their diet, lose weight, exercise regularly and stop smoking. Drugs should only be used in those who do not respond to such treatment or those who have CHD or risk factors for CHD.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1993
User Contributions:
Comment about this article or add new information about this topic:
Severe mental illness and risk of cardiovascular disease
Article Abstract:
The article discusses about the disparities in cardiovascular disease mortality and prevention efforts by comparing the general population and individuals with severe mental illness and emphasizing the urgent need for new paradigms.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Oral contraception in disease states. Modern oral contraceptives and cardiovascular disease
- Abstracts: Tracheal resection and reconstruction: indications, surgical procedure, and postoperative care. Differential effects of continuous versus intermittent suction on tracheal tissue
- Abstracts: Changes in physician practice for the prevention of cardiovascular disease. part 2 Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia
- Abstracts: "Think PID": new directions in prevention and management of pelvic inflammatory disease. Partner notification to prevent pelvic inflammatory disease in women: cost-effectiveness of two strategies
- Abstracts: Fetal blood sampling and pregnancy loss in relation to indication. Partial placenta menbranacea